Literature DB >> 9760015

Antioxidant status in hyperphenylalaninemia.

C Sierra1, M A Vilaseca, D Moyano, N Brandi, J Campistol, N Lambruschini, F J Cambra, R Deulofeu, A Mira.   

Abstract

Abnormal oxidative stress was observed in some inborn errors of metabolism owing to the accumulation of toxic metabolites leading to excessive free radical production and to the influence of restricted diets on the antioxidant status. Erythrocyte antioxidant enzymes activities and tocopherol concentrations were measured in a group of phenylketonuric (n = 42) and mild-hyperphenylalaninemic (n = 28) patients compared with 45 age-matched controls. We also determined plasma selenium levels in these groups. We also evaluated the possible relationship between antioxidant status and neuropsychological disorders. Erythrocyte glutathione peroxidase (GSH-Px) activity was significantly lower (P < 0.001) in both phenylketonuric and mild-hyperphenylalaninemic patients compared with the control group, but no differences were observed between the two groups of patients. Neuropsychological disturbances were more frequent in the group of PKU patients with low GSH-Px activity than in PKU patients with normal GSH-Px. Low GSH-Px activity might be explained in phenylketonuria as a result of a selenium deficiency caused by a poor selenium intake or absorption, but not in mild hyperphenylalaninemic patients with free diet. Selenium levels were normal in both groups of patients, so low glutathione peroxidase activity in both phenylketonuric and hyperphenylalaninemic groups might be influenced by other factors, such as the consequences of an unbalanced amino acid profile, common to both conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760015     DOI: 10.1016/s0009-8981(98)00091-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.

Authors:  Jennifer E Embury; Catherine E Charron; Anatoly Martynyuk; Andreas G Zori; Bin Liu; Syed F Ali; Neil E Rowland; Philip J Laipis
Journal:  Brain Res       Date:  2006-11-15       Impact factor: 3.252

3.  Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.

Authors:  Priscila Nicolao Mazzola; Melaine Terra; Andrea Pereira Rosa; Caroline Paula Mescka; Tarsila Barros Moraes; Bruna Piccoli; Carlos Eduardo Jacques; Giovana Dalazen; Marcelo Xavier Cortes; Juliana Coelho; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2011-09-27       Impact factor: 3.584

Review 4.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

5.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

6.  Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.

Authors:  Tarsila Barros Moraes; Carlos Eduardo Diaz Jacques; Andrea Pereira Rosa; Giovana Reche Dalazen; Melaine Terra; Juliana Gonzalez Coelho; Carlos Severo Dutra-Filho
Journal:  Cell Mol Neurobiol       Date:  2012-12-12       Impact factor: 5.046

7.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

8.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

9.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

10.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.